HighMark Wealth Management »

Qualigen Therapeutics shares owned by HighMark Wealth Management

Quarter-by-quarter ownership of Qualigen Therapeutics (QLGN) shares owned by HighMark Wealth Management from 13F filings

Historical chart of HighMark Wealth Management investment in Qualigen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Qualigen Therapeutics held by HighMark Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Qualigen Therapeutics by HighMark Wealth Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $915 160 5.72
2025-06-30 $546 160 3.41
2025-03-31 $582 160 3.64
2024-12-31 $674 160 4.21

More positions owned by HighMark Wealth Management

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Eafe Value Etf (EFV)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Core S&p Scp Etf (IJR)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p Us Vlu (IUSV)
Wells Fargo & Company (WFC)
Performant Finl (PHLT)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Anaptysbio Inc Common (ANAB)
Invesco Exch Traded Fd Tr Ii Dorsey Wrgt Smlc (DWAS)
Ishares Tr Core S&p Mcp Etf (IJH)
Axogen (AXGN)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Neogenomics Com New (NEO)

View all positions for HighMark Wealth Management

Top funds holding Qualigen Therapeutics

Cubist Systematic Strategies
UBS Group
BlackRock
Tower Research Capital
Harbour Investments
Stone House Investment Management
HighMark Wealth Management
Group One Trading
Us Bancorp
UMA Financial Services
SBI Securities
Danske Bank A/s

View all funds holding Qualigen Therapeutics